Mh. Ebert et al., ELEVATED PLASMA GAMMA-AMINOBUTYRIC-ACID (GABA) LEVELS IN INDIVIDUALS WITH EITHER PRADER-WILLI-SYNDROME OR ANGELMAN SYNDROME, The Journal of neuropsychiatry and clinical neurosciences, 9(1), 1997, pp. 75-80
Plasma gamma-aminobutyric acid (GABA) levels were measured in 14 subje
cts with Prader-Willi syndrome, 9 subjects with Angelman syndrome, and
matched control subjects. Mean levels in both patient groups were 2 t
o 3 times higher than in nonretarded moderately obese or retarded nono
bese control subjects. Levels in each patient group differed significa
ntly from both control groups. Neither the two patient groups nov the
two control groups differed. GABA levels seemed unrelated to genetic s
tatus (chromosome 15 deletion or disomy). These preliminary findings o
f elevated plasma GABA levels possibly represent a compensatory increa
se in presynaptic GABA release in response to hyposensitivity of a sub
set of GABA receptors and could produce increased postsynaptic activat
ion of other normal GABA receptor subtypes, resulting in complex alter
ations of GABAergic function throughout the brain.